These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 16996907

  • 1. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H, Sato N, Hiyama M, Kaimori M, Endo S, Sohara Y, Imai T.
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [Abstract] [Full Text] [Related]

  • 2. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Apr 01; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 01; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 7. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul 15; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 8. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O.
    Cancer; 1997 Sep 15; 80(6):1034-45. PubMed ID: 9305703
    [Abstract] [Full Text] [Related]

  • 9. Prognostic evaluation of COX-2 expression in renal cell carcinoma.
    Kankuri-Tammilehto MK, Söderström KO, Pelliniemi TT, Vahlberg T, Pyrhönen SO, Salminen EK.
    Anticancer Res; 2010 Jul 15; 30(7):3023-30. PubMed ID: 20683050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 15; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 12. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM, Reis MM, Palomino SA, Farhat C, Takagaki TY, Beyruti R, Saldiva PH, Capelozzi VL.
    Mod Pathol; 2000 May 15; 13(5):511-20. PubMed ID: 10824922
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun 15; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M.
    Lung Cancer; 2004 Oct 15; 46(1):77-85. PubMed ID: 15364135
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H, Ohta M, Tanaka H, Sakaguchi M, Fujii Y, Miyoshi S, Matsuda H.
    J Surg Oncol; 2002 Dec 15; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [Abstract] [Full Text] [Related]

  • 18. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T, Mori M.
    Ann Surg Oncol; 2009 Dec 15; 16(12):3473-81. PubMed ID: 19777189
    [Abstract] [Full Text] [Related]

  • 19. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.